Symbols / FOXO Stock $0.00 +0.00% FOXO Technologies Inc.
FOXO (Stock) Chart
About
FOXO Technologies Inc. operates as a healthcare services and technology company in the United States. The company operates through two segments: Healthcare and Labs and Life. The company offers behavioural health; ancillary, including laboratory, radiology, respiratory, and pharmacy; insurance; and other services. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in West Palm Beach, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 306.27K |
| Enterprise Value | 10.18M | Income | -23.24M | Sales | 14.76M |
| Book/sh | 0.19 | Cash/sh | 0.00 | Dividend Yield | — |
| Payout | 0.00% | Employees | 102 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.02 | P/B | 0.00 | P/C | — |
| EV/EBITDA | -3.27 | EV/Sales | 0.69 | Quick Ratio | 0.13 |
| Current Ratio | 0.14 | Debt/Eq | 53.98 | LT Debt/Eq | — |
| EPS (ttm) | -7.13 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 196.50% | Earnings | — | ROA | -5.25% |
| ROE | -7.61% | ROIC | — | Gross Margin | 46.74% |
| Oper. Margin | -24.23% | Profit Margin | -66.46% | Shs Outstand | 3.06B |
| Shs Float | 491.34M | Short Float | 4.34% | Short Ratio | 0.10 |
| Short Interest | — | 52W High | 4.74 | 52W Low | 0.00 |
| Beta | 2.45 | Avg Volume | 21.95M | Volume | 572.00K |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $0.00 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- FOXO Technologies Expands Authorized Class A Share Capacity - TipRanks hu, 02 Apr 2026 16
- FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025. - finance.yahoo.com Wed, 13 Aug 2025 07
- FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health - TradingView Fri, 06 Feb 2026 08
- FOXO Technologies (OTC: FOXO) unit Myrtle Recovery serves 63 of 95 TN counties - Stock Titan ue, 09 Dec 2025 08
- Form PRE 14C FOXO TECHNOLOGIES INC. For: Apr 01 - StreetInsider Wed, 01 Apr 2026 18
- FOXO Technologies delisted from NYSE, begins trading on OTC - Investing.com Wed, 13 Aug 2025 07
- FOXO announces closing of Vector BioSource acquisition - Coverager Mon, 20 Oct 2025 07
- FOXO Technologies announces 1 for 10 reverse stock split - MSN Mon, 29 Dec 2025 16
- FOXO Technologies Delays Annual 10-K Filing - TipRanks Wed, 01 Apr 2026 01
- FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT - finance.yahoo.com hu, 17 Jul 2025 07
- CFO change at FOXO Technologies (FOXO) amid control and reporting concerns - Stock Titan ue, 24 Mar 2026 07
- Foxo Technologies majority stockholder approves potential reverse stock split - Investing.com Mon, 08 Sep 2025 07
- FOXO Stock Price and Chart — OTC:FOXO - TradingView hu, 14 Aug 2025 11
- FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONS - finance.yahoo.com Fri, 27 Jun 2025 07
- FOXO Technologies Names New CFO After Abrupt Resignation - TipRanks ue, 24 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
4.05
+2688.61%
|
0.15
-71.57%
|
0.51
+325.83%
|
0.12
|
| Operating Revenue |
|
4.05
+2688.61%
|
0.15
-71.57%
|
0.51
+325.83%
|
0.12
|
| Cost Of Revenue |
|
2.48
+1776.01%
|
0.13
-61.50%
|
0.34
|
0.00
|
| Reconciled Cost Of Revenue |
|
2.48
+1776.01%
|
0.13
-61.50%
|
0.34
|
0.00
|
| Gross Profit |
|
1.57
+12084.09%
|
0.01
-92.30%
|
0.17
+39.17%
|
0.12
|
| Operating Expense |
|
7.54
-62.87%
|
20.30
-29.69%
|
28.87
+90.57%
|
15.15
|
| Research And Development |
|
0.31
-65.32%
|
0.90
-70.45%
|
3.05
-37.55%
|
4.88
|
| Selling General And Administration |
|
7.23
-62.76%
|
19.40
-24.88%
|
25.83
+151.42%
|
10.27
|
| Total Expenses |
|
10.02
-50.95%
|
20.43
-30.07%
|
29.22
+92.84%
|
15.15
|
| Operating Income |
|
-5.97
+70.57%
|
-20.29
+29.33%
|
-28.71
-90.98%
|
-15.03
|
| Total Operating Income As Reported |
|
-7.76
+65.02%
|
-22.19
+44.76%
|
-40.17
-167.23%
|
-15.03
|
| EBITDA |
|
-7.28
+69.82%
|
-24.11
+73.88%
|
-92.30
-147.64%
|
-37.27
|
| Normalized EBITDA |
|
-5.02
+73.55%
|
-18.99
+65.83%
|
-55.58
-50.73%
|
-36.87
|
| Reconciled Depreciation |
|
1.24
-3.43%
|
1.28
-15.58%
|
1.51
+1445.92%
|
0.10
|
| EBIT |
|
-8.51
+66.48%
|
-25.39
+72.94%
|
-93.81
-151.04%
|
-37.37
|
| Total Unusual Items |
|
-2.25
+55.99%
|
-5.12
+86.06%
|
-36.72
-9080.50%
|
-0.40
|
| Total Unusual Items Excluding Goodwill |
|
-2.25
+55.99%
|
-5.12
+86.06%
|
-36.72
-9080.50%
|
-0.40
|
| Special Income Charges |
|
-2.22
+59.05%
|
-5.42
+52.70%
|
-11.46
-2765.25%
|
-0.40
|
| Other Special Charges |
|
0.43
-87.83%
|
3.52
|
—
|
—
|
| Impairment Of Capital Assets |
|
1.85
-29.81%
|
2.63
+92.17%
|
1.37
|
—
|
| Restructuring And Mergern Acquisition |
|
-0.06
+92.32%
|
-0.73
-107.26%
|
10.09
|
0.00
|
| Write Off |
|
—
|
—
|
0.00
-100.00%
|
0.40
|
| Net Income |
|
-12.41
+53.10%
|
-26.45
+72.23%
|
-95.25
-147.49%
|
-38.49
|
| Pretax Income |
|
-12.42
+53.04%
|
-26.45
+72.23%
|
-95.25
-147.49%
|
-38.49
|
| Net Non Operating Interest Income Expense |
|
-3.91
-267.62%
|
-1.06
+26.13%
|
-1.44
-28.80%
|
-1.12
|
| Interest Expense Non Operating |
|
3.91
+267.62%
|
1.06
-26.13%
|
1.44
+28.80%
|
1.12
|
| Net Interest Income |
|
-3.91
-267.62%
|
-1.06
+26.13%
|
-1.44
-28.80%
|
-1.12
|
| Interest Expense |
|
3.91
+267.62%
|
1.06
-26.13%
|
1.44
+28.80%
|
1.12
|
| Other Income Expense |
|
-2.54
+50.18%
|
-5.10
+92.17%
|
-65.11
-191.46%
|
-22.34
|
| Other Non Operating Income Expenses |
|
-0.29
-1629.25%
|
0.02
+100.07%
|
-28.39
-29.39%
|
-21.94
|
| Gain On Sale Of Security |
|
-0.03
-110.72%
|
0.30
+101.20%
|
-25.26
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-12.42
+53.04%
|
-26.45
+72.23%
|
-95.25
-147.49%
|
-38.49
|
| Net Income From Continuing Operation Net Minority Interest |
|
-12.41
+53.10%
|
-26.45
+72.23%
|
-95.25
-147.49%
|
-38.49
|
| Net Income From Continuing And Discontinued Operation |
|
-12.41
+53.10%
|
-26.45
+72.23%
|
-95.25
-147.49%
|
-38.49
|
| Net Income Continuous Operations |
|
-12.42
+53.04%
|
-26.45
+72.23%
|
-95.25
-147.49%
|
-38.49
|
| Minority Interests |
|
0.01
|
0.00
|
—
|
—
|
| Normalized Income |
|
-10.15
+52.40%
|
-21.33
+63.56%
|
-58.53
-53.68%
|
-38.09
|
| Net Income Common Stockholders |
|
-13.56
+54.54%
|
-29.83
+68.68%
|
-95.25
-147.49%
|
-38.49
|
| Otherunder Preferred Stock Dividend |
|
1.07
-68.21%
|
3.38
|
0.00
|
—
|
| Diluted EPS |
|
-18.51
+86.86%
|
-140.89
+91.57%
|
-1,671.60
-639.04%
|
-226.18
|
| Basic EPS |
|
-18.51
+86.86%
|
-140.89
+91.57%
|
-1,671.60
-639.04%
|
-226.18
|
| Basic Average Shares |
|
0.73
+246.59%
|
0.21
+271.79%
|
0.06
-66.51%
|
0.17
|
| Diluted Average Shares |
|
0.73
+246.59%
|
0.21
+271.79%
|
0.06
-66.51%
|
0.17
|
| Diluted NI Availto Com Stockholders |
|
-13.56
+54.54%
|
-29.83
+68.68%
|
-95.25
-147.49%
|
-38.49
|
| Preferred Stock Dividends |
|
1.16
-65.81%
|
3.38
|
—
|
—
|
| Total Other Finance Cost |
|
—
|
—
|
—
|
1.12
|
| Line Item | Trend | 2022-12-31 |
|---|---|---|
| Total Assets |
|
35.41
|
| Current Assets |
|
12.30
|
| Cash Cash Equivalents And Short Term Investments |
|
5.51
|
| Cash And Cash Equivalents |
|
5.51
|
| Receivables |
|
—
|
| Accounts Receivable |
|
—
|
| Inventory |
|
1.31
|
| Raw Materials |
|
1.31
|
| Prepaid Assets |
|
5.36
|
| Other Current Assets |
|
0.11
|
| Total Non Current Assets |
|
23.10
|
| Net PPE |
|
—
|
| Gross PPE |
|
—
|
| Accumulated Depreciation |
|
—
|
| Properties |
|
—
|
| Machinery Furniture Equipment |
|
—
|
| Other Properties |
|
—
|
| Leases |
|
—
|
| Goodwill And Other Intangible Assets |
|
2.04
|
| Goodwill |
|
—
|
| Other Intangible Assets |
|
2.04
|
| Investments And Advances |
|
—
|
| Long Term Equity Investment |
|
—
|
| Non Current Accounts Receivable |
|
18.57
|
| Other Non Current Assets |
|
2.49
|
| Total Liabilities Net Minority Interest |
|
28.70
|
| Current Liabilities |
|
6.91
|
| Payables And Accrued Expenses |
|
4.46
|
| Payables |
|
3.97
|
| Accounts Payable |
|
3.47
|
| Current Accrued Expenses |
|
0.49
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
1.04
|
| Total Tax Payable |
|
—
|
| Current Debt And Capital Lease Obligation |
|
1.41
|
| Current Debt |
|
1.41
|
| Other Current Borrowings |
|
1.41
|
| Current Capital Lease Obligation |
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
21.79
|
| Long Term Debt And Capital Lease Obligation |
|
1.73
|
| Long Term Debt |
|
1.73
|
| Long Term Capital Lease Obligation |
|
—
|
| Long Term Provisions |
|
18.57
|
| Non Current Deferred Liabilities |
|
—
|
| Other Non Current Liabilities |
|
1.17
|
| Stockholders Equity |
|
6.71
|
| Common Stock Equity |
|
6.71
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
0.15
|
| Ordinary Shares Number |
|
0.14
|
| Treasury Shares Number |
|
0.01
|
| Additional Paid In Capital |
|
153.94
|
| Retained Earnings |
|
-147.23
|
| Treasury Stock |
|
0.00
|
| Minority Interest |
|
—
|
| Total Equity Gross Minority Interest |
|
6.71
|
| Total Capitalization |
|
8.44
|
| Working Capital |
|
5.39
|
| Invested Capital |
|
9.85
|
| Total Debt |
|
3.14
|
| Net Debt |
|
—
|
| Capital Lease Obligations |
|
—
|
| Net Tangible Assets |
|
4.67
|
| Tangible Book Value |
|
4.67
|
| Current Notes Payable |
|
—
|
| Current Provisions |
|
—
|
| Derivative Product Liabilities |
|
0.31
|
| Dueto Related Parties Current |
|
0.50
|
| Interest Payable |
|
—
|
| Preferred Stock Equity |
|
—
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-2.84
+57.25%
|
-6.65
+72.03%
|
-23.76
-57.82%
|
-15.05
|
| Cash Flow From Continuing Operating Activities |
|
-2.84
+57.25%
|
-6.65
+72.03%
|
-23.76
-57.82%
|
-15.05
|
| Net Income From Continuing Operations |
|
-12.42
+53.04%
|
-26.45
+72.23%
|
-95.25
-147.49%
|
-38.49
|
| Depreciation Amortization Depletion |
|
1.24
-3.43%
|
1.28
-15.58%
|
1.51
+1445.92%
|
0.10
|
| Depreciation |
|
—
|
1.28
-15.58%
|
1.51
+1445.92%
|
0.10
|
| Depreciation And Amortization |
|
1.24
-3.43%
|
1.28
-15.58%
|
1.51
+1445.92%
|
0.10
|
| Other Non Cash Items |
|
3.36
-56.93%
|
7.80
-78.32%
|
35.96
+61.74%
|
22.23
|
| Stock Based Compensation |
|
-0.10
-126.68%
|
0.38
-96.54%
|
11.04
+8323.66%
|
0.13
|
| Asset Impairment Charge |
|
1.85
-29.79%
|
2.63
+92.17%
|
1.37
+242.50%
|
0.40
|
| Operating Gains Losses |
|
0.46
+252.28%
|
-0.30
-101.21%
|
24.97
|
—
|
| Gain Loss On Investment Securities |
|
0.03
+110.72%
|
-0.30
-101.21%
|
24.97
|
—
|
| Change In Working Capital |
|
2.78
-65.33%
|
8.02
+339.31%
|
-3.35
-685.84%
|
0.57
|
| Change In Receivables |
|
0.55
-97.02%
|
18.57
+1986.90%
|
0.89
+191.80%
|
0.30
|
| Changes In Account Receivables |
|
0.55
|
0.00
|
—
|
—
|
| Change In Inventory |
|
0.04
-96.93%
|
1.31
+229.00%
|
-1.02
-245.08%
|
-0.29
|
| Change In Prepaid Assets |
|
0.10
-96.77%
|
3.05
+207.86%
|
-2.83
-2520.51%
|
0.12
|
| Change In Payables And Accrued Expense |
|
2.94
-19.25%
|
3.65
+48.07%
|
2.46
-24.08%
|
3.24
|
| Change In Accrued Expense |
|
1.79
-43.28%
|
3.15
+34.89%
|
2.34
+1416.88%
|
0.15
|
| Change In Payable |
|
1.16
+133.47%
|
0.50
+290.36%
|
0.13
-95.89%
|
3.09
|
| Change In Account Payable |
|
1.16
+133.47%
|
0.50
+290.36%
|
0.13
-95.89%
|
3.09
|
| Change In Other Working Capital |
|
—
|
-18.57
-1986.90%
|
-0.89
-191.80%
|
-0.30
|
| Change In Other Current Assets |
|
-1.37
-29736.52%
|
0.00
+100.23%
|
-1.96
+21.25%
|
-2.49
|
| Change In Other Current Liabilities |
|
0.51
|
0.00
|
—
|
—
|
| Investing Cash Flow |
|
0.01
|
0.00
+100.00%
|
-1.87
-426.76%
|
-0.35
|
| Cash Flow From Continuing Investing Activities |
|
0.01
|
0.00
+100.00%
|
-1.87
-426.76%
|
-0.35
|
| Net PPE Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.11
+6.78%
|
-0.12
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-0.11
+6.78%
|
-0.12
|
| Capital Expenditure |
|
—
|
—
|
-1.87
-672.73%
|
-0.24
|
| Net Investment Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Purchase Of Investment |
|
—
|
—
|
—
|
0.00
|
| Net Business Purchase And Sale |
|
0.01
|
0.00
|
—
|
—
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-1.76
-1319.35%
|
-0.12
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-1.76
-1319.35%
|
-0.12
|
| Net Other Investing Changes |
|
—
|
—
|
—
|
-0.11
|
| Financing Cash Flow |
|
2.86
+144.73%
|
1.17
-95.19%
|
24.29
+71.74%
|
14.14
|
| Cash Flow From Continuing Financing Activities |
|
2.86
+144.73%
|
1.17
-95.19%
|
24.29
+71.74%
|
14.14
|
| Net Issuance Payments Of Debt |
|
2.81
+865.06%
|
0.29
-99.04%
|
30.30
+188.55%
|
10.50
|
| Issuance Of Debt |
|
4.09
+1305.08%
|
0.29
-99.07%
|
31.46
+199.60%
|
10.50
|
| Repayment Of Debt |
|
-1.28
|
0.00
+100.00%
|
-1.16
|
0.00
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
0.29
-99.07%
|
31.46
|
0.00
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
0.29
-99.07%
|
31.46
|
0.00
|
| Short Term Debt Issuance |
|
4.09
|
0.00
-100.00%
|
28.00
+166.67%
|
10.50
|
| Short Term Debt Payments |
|
-1.28
|
0.00
+100.00%
|
-1.16
|
0.00
|
| Net Short Term Debt Issuance |
|
2.81
|
0.00
+100.00%
|
-1.16
-111.05%
|
10.50
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
1.18
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
+100.00%
|
-0.51
|
0.00
|
| Net Other Financing Charges |
|
-0.04
+85.97%
|
-0.30
+94.56%
|
-5.50
-251.03%
|
3.64
|
| Changes In Cash |
|
0.03
+100.55%
|
-5.48
-308.46%
|
-1.34
-5.84%
|
-1.27
|
| Beginning Cash Position |
|
0.04
-99.31%
|
5.52
-19.55%
|
6.86
-15.60%
|
8.12
|
| End Cash Position |
|
0.07
+79.11%
|
0.04
-99.31%
|
5.51
-19.56%
|
6.86
|
| Free Cash Flow |
|
-2.84
+57.25%
|
-6.65
+74.07%
|
-25.63
-67.55%
|
-15.30
|
| Interest Paid Supplemental Data |
|
—
|
0.00
-100.00%
|
1.22
+7.78%
|
1.13
|
| Income Tax Paid Supplemental Data |
|
—
|
0.00
|
0.00
|
—
|
| Amortization Of Securities |
|
—
|
—
|
—
|
-0.03
|
| Common Stock Issuance |
|
0.00
-100.00%
|
1.18
|
0.00
|
—
|
| Issuance Of Capital Stock |
|
0.09
-92.35%
|
1.18
|
0.00
|
—
|
| Net Preferred Stock Issuance |
|
0.09
|
0.00
|
—
|
—
|
| Preferred Stock Issuance |
|
0.09
|
0.00
|
—
|
—
|
| Sale Of Business |
|
0.01
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-02 View
- 8-K2026-03-24 View
- 8-K2026-02-06 View
- 8-K2026-01-20 View
- 8-K2025-12-19 View
- 8-K2025-12-16 View
- 8-K2025-12-10 View
- 10-Q2025-11-10 View
- 8-K2025-11-04 View
- 8-K2025-10-23 View
- 8-K2025-09-26 View
- 8-K2025-09-22 View
- 8-K2025-09-16 View
- 8-K2025-09-15 View
- 8-K2025-09-15 View
- 8-K2025-09-08 View
- 8-K2025-09-08 View
- 10-Q2025-08-19 View
- 8-K2025-08-18 View
- 8-K2025-08-13 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|